Founder & Chief Scientific Officer at Q32 Bio
Intro paths
β
In turn, Shelia can intro founders to Q32 Bio's investors below.
Q32 Bio's investors Β· 6
Co-founders at Q32 Bio
MH
Michael HolersCo-founder
Experience
- Atlas VentureAdvisorcurrent2021 β presentCambridge, Massachusetts, United States
- Q32 Bio Inc.Co-founder, Chief Scientific Officer and President of Researchcurrent2017 β presentCambridge, Massachusetts, United States
- Yale University School of MedicineAdjunct Associate Professor, Dept. of Internal Medicine, Section of Pulmonary2016 β 2021New Haven, CT
- Atlas VentureEntrepreneur In Residence2016 β 2020Cambridge, MA
- BiogenVice President, Tissue Injury and Fibrosis2015 β 2016Cambridge, MA
- BiogenSenior Director, Tissue Injury and Fibrosis2013 β 2015Cambridge, MA
- BiogenSenior Director, BG00011 program executive2012 β 2013Cambridge, MA
- StromedixVice President, Research2008 β 2012
- Biogen IdecDirector, Immunology2007 β 2008
- Biogen IdecResearch Head, Fibrosis / Associate Director, Molecular Cell Biology and Immunology2003 β 2007Cambridge, MA
- Biogen IdecSenior Scientist / Principal Scientist / alphavbeta6 Project Leader, Inflammation1999 β 2003Cambridge, MA
- ARIAD Pharmaceuticals, Inc.Principal Scientist / Staff Scientist, Biology and Signal Transduction1996 β 1999Cambridge, MA
- Repligen CorporationResearch Scientist / Principal Investigator, Inflammation and Molecular Pharmacology1992 β 1996
- Yale University, Department of BiologyPostdoctoral Research Fellow1988 β 1992New Haven, CT
Frequently asked questions
- Who is Shelia Violette?
- Founder & Chief Scientific Officer at Q32 Bio
- Where does Shelia Violette work?
- Shelia Violette is Founder & Chief Scientific Officer of Q32 Bio.
- What companies did Shelia Violette found?
- Shelia Violette founded Q32 Bio.
- Where did Shelia Violette go to school?
- Shelia Violette studied at Yale University (Ph.D., Pharmacology).
Same school
Shared employers
Also worked at Q32 Bio Inc.5
Also worked at Yale University School of Medicine67
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Brittany de KouchkovskyDirector, University Relations at Osage University PartnersDavid Rosenthal, MDVenture Partner at AlleyCorpAlley (Welsh) OlshanskyAdvisor at Casdin CapitalSophie RobinsonSenior Associate at Cure VenturesMichael RechtChair, P2C Scientific Advisory Group and Chief Medical and Scientific Advisor at Pathway to Cures
+ 61 more
Also worked at Atlas Venture64
Karim FarisInvestor at GV (Google Ventures)Nessan BerminghamInvestor at Khosla VenturesKristen LaguerreExecutive Partner at MPM BioImpactJeanne HenryCFO at Excel Venture ManagementGretchen McCareyChief Financial Officer at Castle Island VenturesKate GunioController at Long Ridge Equity Partners
+ 58 more
Also worked at Biogen44
Jigar RaythathaInvestor at Third Rock VenturesRichard RansohoffVenture Partner at Third Rock VenturesIsaiah Baril-DoreInvestor at Index VenturesSteve HoltzmanBio Advisor at Amplify PartnersRoy LobbVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD Longevity
+ 38 more





























